A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore and examine endpoints that allow evaluation of the
"clinically significant improvements, focusing on the patient's chief complaint and the
severity of major IBS symptoms" by this drug in patients with diarrhea-predominant irritable
bowel syndrome (IBS).